Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/VTRS
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $17.42, up 1.75% today, with a bullish technical signal from moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.69, exceeding expectations, and announced a $0.12 dividend for September 2026. Revenue trends show stability around $14.3B, though net income remains negative. Analyst consensus is a $21.40 price target with a mixed rating distribution.
Outlook is cautiously optimistic due to strong cash flow and pipeline progress, but risks include persistent negative margins, high debt, and regulatory pressures from potential generic drug tariffs. The stock offers value with low P/S and P/B ratios, yet profitability challenges and competitive pressures warrant careful monitoring for sustained turnaround.
Read full analysis

Key Stats

  • Market Cap
    $20.01B
  • Volume
    13,743,812
  • Sector
    Health
  • 52W High
    $17.86
  • 52W Low
    $9.52
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $32.12B
  • Div Yield
    2.76%
  • Trading Activity
    -
$17.83
52W Low: $9.52
26 Sep 2025
52W High: $17.86
28 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $9.52 and a high of $17.86, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

C3.ai CEO Thomas Siebel sells 66,752 shares to cover tax withholding.

Thomas Siebel, CEO of C3.ai, has sold 66,752 shares of the company to cover tax withholding obligations. This transaction is a routine financial move related to tax compliance rather than a strategic sale. Investors should note this is a standard pra...

Market News
3 hours ago
Robert Izquierdo
Bearish
news icon
C3.ai CEO Thomas Siebel sells 66,752 shares to cover tax withholding.

Chinese AI models gain majority token use on developer platforms amid US security concerns

Chinese AI models have rapidly increased their usage on major developer platforms OpenRouter and Vercel in 2026, now accounting for over half of token usage. Their lower cost and strong performance, especially in coding tasks, have driven adoption gl...

Market News
4 hours ago
CNBC
Neutral
Chinese AI models gain majority token use on developer platforms amid US security concerns

Law firm probes BellRing Brands officers for possible breaches of duty to shareholders.

Halper Sadeh LLC is investigating whether certain officers and directors of BellRing Brands, Inc. breached their fiduciary duties to shareholders. Long-term BellRing stockholders may be eligible to seek corporate governance reforms, financial incenti...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
Law firm probes BellRing Brands officers for possible breaches of duty to shareholders.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $20.01B
  • Volume
    13,743,812
  • Sector
    Health
  • 52W High
    $17.86
  • 52W Low
    $9.52
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $32.12B
  • Div Yield
    2.76%
  • Trading Activity
    -
$17.83
52W Low: $9.52
26 Sep 2025
52W High: $17.86
28 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $9.52 and a high of $17.86, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!